{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:01:22Z","timestamp":1789441282115,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:00:00Z","timestamp":1509753600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373187"],"award-info":[{"award-number":["81373187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10067-017-3891-3","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T03:46:00Z","timestamp":1509767160000},"page":"227-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus"],"prefix":"10.1007","volume":"37","author":[{"given":"Zhen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-7553","authenticated-orcid":false,"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,4]]},"reference":[{"key":"3891_CR1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(00)04239-2","volume":"357","author":"G Ruiz-Irastorza","year":"2001","unstructured":"Ruiz-Irastorza G, Khamashta MA, Castellino G et al (2001) Systemic lupus erythematosus. Lancet 357:1027\u20131032","journal-title":"Lancet"},{"issue":"4","key":"3891_CR2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00415-011-6232-5","volume":"259","author":"MB Lauvsnes","year":"2012","unstructured":"Lauvsnes MB, Omdal R (2012) Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J Neurol 259(4):622\u2013629","journal-title":"J Neurol"},{"issue":"10","key":"3891_CR3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","volume":"10","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S (2014) Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 10(10):579\u2013596","journal-title":"Nat Rev Neurol"},{"key":"3891_CR4","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ et al (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985\u2013992","journal-title":"J Rheumatol"},{"key":"3891_CR5","first-page":"1536","volume":"29","author":"WL Sibbitt Jr","year":"2002","unstructured":"Sibbitt WL Jr, Brandt JR, Johnson CR et al (2002) The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29:1536\u20131542","journal-title":"J Rheumatol"},{"key":"3891_CR6","doi-asserted-by":"publisher","unstructured":"Tay SH (2016) Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot? Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/kew338","DOI":"10.1093\/rheumatology\/kew338"},{"key":"3891_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2016.06.013","volume":"74","author":"M Govoni","year":"2016","unstructured":"Govoni M, Bortoluzzi A, Padovan M et al (2016) The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun 74:41\u201372","journal-title":"J Autoimmun"},{"key":"3891_CR8","unstructured":"Schur PH (2009) Know your labs: a review of state-of-the-art testing for SLE and connective tissue disease. The Rheumatologist. February"},{"key":"3891_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1741-7015-11-98","volume":"11","author":"D C armona-Fernandes","year":"2013","unstructured":"C armona-Fernandes D, Santos MJ, Canh H\u00e3o H, Fonseca JE (2013) Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med 11:98","journal-title":"BMC Med"},{"issue":"12","key":"3891_CR10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/41.12.1357","volume":"41","author":"R Gerli","year":"2002","unstructured":"Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, De Angelis V, Cesarotti M, Piccirilli M, Quartesan R, Moretti P, Cantoni C, Franceschini F, Cavazzana I, Origgi L, Vanoli M, Bozzolo E, Ferrario L, Padovani A, Gambini O, Vanzulli L, Croce D, Bombardieri S (2002) Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) 41(12):1357\u20131366","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3891_CR11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00109-010-0618-1","volume":"88","author":"LL Heinlen","year":"2010","unstructured":"Heinlen LL, Ritterhouse LL, McClain MT, Keith MP, Neas BR, Harley JB, James JA (2010) Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med 88(7):719\u2013727","journal-title":"J Mol Med"},{"issue":"4","key":"3891_CR12","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4049\/jimmunol.159.4.2033","volume":"159","author":"M Koscec","year":"1997","unstructured":"Koscec M, Koren E, Wolfson-Reichlin M, Fugate RD, Trieu E, Targoff IN, Reichlin M (1997) Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 159(4):2033","journal-title":"J Immunol"},{"key":"3891_CR13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1191\/0961203305lu2150rr","volume":"14","author":"T Eber","year":"2005","unstructured":"Eber T, Chapman J, Shoenfeld Y (2005) Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 14:571\u2013575","journal-title":"Lupus"},{"issue":"1","key":"3891_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/art.38900","volume":"67","author":"M Bravo-Zehnder","year":"2015","unstructured":"Bravo-Zehnder M, Toledo EM, Segovia-Miranda F, Serrano FG, Benito MJ, Metz C, Retamal C, \u00c1lvarez A, Massardo L, Inestrosa NC, Gonz\u00e1lez A (2015) Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis Rheumatol 67(1):204\u2013214. https:\/\/doi.org\/10.1002\/art.38900","journal-title":"Arthritis Rheumatol"},{"key":"3891_CR15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","volume":"54","author":"FB Karassa","year":"2006","unstructured":"Karassa FB, Afeltra A, Ambrozic A et al (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 54:312","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3891_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","volume":"63","author":"J Luyendijk","year":"2011","unstructured":"Luyendijk J, Steens SC, Ouwendijk WJ, Steup-Beekman GM, Bollen EL, van der Grond J, Huizinga TW, Emmer BJ, van Buchem MA (2011) Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum 63(3):722\u2013732","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3891_CR17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725","journal-title":"Arthritis Rheum"},{"key":"3891_CR18","doi-asserted-by":"crossref","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1999) Arthritis Rheum; 42:599\u2013608","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"issue":"5","key":"3891_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 82(5):299\u2013308","journal-title":"Medicine"},{"issue":"12","key":"3891_CR20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.autrev.2013.07.004","volume":"12","author":"P Toledano","year":"2013","unstructured":"Toledano P, Sarbu N, Espinosa G, Bargall\u00f3 N, Cervera R (2013) Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. Autoimmun Rev 12(12):1166\u20131170","journal-title":"Autoimmun Rev"},{"issue":"7","key":"3891_CR21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0961203313488840","volume":"22","author":"SA Kohut","year":"2013","unstructured":"Kohut SA, Williams TS, Jayanthikumar J (2013) Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE). Lupus 22(7):712\u2013720","journal-title":"Lupus"},{"key":"3891_CR22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s00415-003-0223-0","volume":"250","author":"T Csepany","year":"2003","unstructured":"Csepany T, Bereczki D, Kollar J, Sikula J, Kiss E, Csiba L (2003) MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J Neurol 250:1348\u20131354","journal-title":"J Neurol"},{"key":"3891_CR23","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J","volume":"42","author":"WL Sibbitt Jr","year":"1999","unstructured":"Sibbitt WL Jr, Sibbitt RR, Brooks WM (1999) Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42:2026\u20132038","journal-title":"Arthritis Rheum"},{"key":"3891_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2012.08.014","volume":"12","author":"S Sciascia","year":"2013","unstructured":"Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G (2013) Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 12:426\u2013429","journal-title":"Autoimmun Rev"},{"key":"3891_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0333102410372428","volume":"31","author":"AB Tjensvoll","year":"2013","unstructured":"Tjensvoll AB, Harboe E, Goransson LG, Beyer MK, Greve OJ, Herigstad A et al (2013) Migraine is frequent in patients with systemic lupus erythematosus: a case-control study. Cephalalgia 31:401\u2013408","journal-title":"Cephalalgia"},{"issue":"12","key":"3891_CR26","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/rheumatology\/ket294","volume":"52","author":"H Fragoso-Loyo","year":"2013","unstructured":"Fragoso-Loyo H, Atisha-Fregoso Y, Llorente L, S\u00e1nchez-Guerrero J (2013) Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 52(12):2218\u20132222","journal-title":"Rheumatology (Oxford)"},{"key":"3891_CR27","first-page":"1459","volume":"32","author":"JG Hanly","year":"2005","unstructured":"Hanly JG, McCurdy G, Fougere L, Douglas J, Thompson K (2005) Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 32:1459\u20131456","journal-title":"J Rheumatol"},{"key":"3891_CR28","first-page":"766","volume":"28","author":"CC Mok","year":"2001","unstructured":"Mok CC, Lau CS, Wong RWS (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766\u2013771","journal-title":"J Rheumatol"},{"issue":"5","key":"3891_CR29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00296-012-2531-0","volume":"33","author":"EA Abda","year":"2013","unstructured":"Abda EA, Selim ZI, Radwan ME et al (2013) Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation. Rheumatol Int 33(5):1243\u20131253","journal-title":"Rheumatol Int"},{"key":"3891_CR30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740510026643","volume":"34","author":"H Ainiala","year":"2005","unstructured":"Ainiala H, Dastidar P, Loukkola J, Lehtimaki T, Korpela M, Peltola J et al (2005) Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 34:376\u2013382","journal-title":"Scand J Rheumatol"},{"key":"3891_CR31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuroimage.2006.09.029","volume":"34","author":"S Appenzeller","year":"2007","unstructured":"Appenzeller S, Bonilha L, Rio PA, Min Li L, Costallat LT, Cendes F (2007) Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. NeuroImage 34:694\u2013701","journal-title":"NeuroImage"},{"key":"3891_CR32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.21483","volume":"64","author":"S Appenzeller","year":"2008","unstructured":"Appenzeller S, Vasconcelos Faria A, Li LM, Costallat LTL, Cendes F (2008) Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients. Ann Neurol 64:635\u2013643","journal-title":"Ann Neurol"},{"key":"3891_CR33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740510026643","volume":"34","author":"H Ainiala","year":"2005","unstructured":"Ainiala H, Dastidar P, Loukkola J, Lehtim\u00e4ki T, Korpela M, Peltola J et al (2005) Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 34:376\u2013382","journal-title":"Scand J Rheumatol"},{"key":"3891_CR34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","volume":"43","author":"J Mikdashi","year":"2004","unstructured":"Mikdashi J, Handwerger B (2004) Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43:1555\u20131560","journal-title":"Rheumatology (Oxford)"},{"key":"3891_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","volume":"93","author":"FB Karassa","year":"2000","unstructured":"Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM (2000) Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM 93:169\u2013174","journal-title":"QJM"},{"key":"3891_CR36","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2741\/1273","volume":"9","author":"H Zaccagni","year":"2004","unstructured":"Zaccagni H, Fried J, Cornell J, Padilla P, Brey RL (2004) Soluble adhesion molecule levels, neuropsychiatric lupus and lupusrelated damage. Front Biosci 9:1654\u20131659","journal-title":"Front Biosci"},{"issue":"7","key":"3891_CR37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0961203314522337","volume":"23","author":"T Yokoyama","year":"2014","unstructured":"Yokoyama T, Fujii T, Kondo-Ishikawa S et al (2014) Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus. Lupus 23(7):635\u2013642","journal-title":"Lupus"},{"key":"3891_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/art.1780350410","volume":"35","author":"S Shiozawa","year":"1992","unstructured":"Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T (1992) Interferonalpha in lupus psychosis. Arthritis Rheum 35:417\u2013422","journal-title":"Arthritis Rheum"},{"key":"3891_CR39","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","volume":"56","author":"H Fragoso-Loyo","year":"2007","unstructured":"Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A et al (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56:1242\u20131250","journal-title":"Arthritis Rheum"},{"key":"3891_CR40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2005.041640","volume":"65","author":"N Iikuni","year":"2006","unstructured":"Iikuni N, Okamoto H, Yoshio T et al (2006) Raised monocyte chemotactic protein-1 (MCP-1)\/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis 65:253\u2013256","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3891-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T19:40:09Z","timestamp":1693165209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3891-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3891-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,4]]}}}